申请人:Pfizer Inc.
公开号:US06410736B1
公开(公告)日:2002-06-25
The present invention relates to compounds of formula I,
and to their pharmaceutically acceptable salts. Compounds of formula I exhibit activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of central nervous system and other disorders.
本发明涉及公式I的化合物及其药学上可接受的盐。公式I的化合物表现出作为血清素、去甲肾上腺素和多巴胺再摄取抑制剂的活性,并可用于治疗中枢神经系统和其他疾病。